{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T12:40:10Z","timestamp":1731933610495,"version":"3.28.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,18]]},"DOI":"10.7759\/cureus.73901","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T12:01:12Z","timestamp":1731931272000},"source":"Crossref","is-referenced-by-count":0,"title":["Reviewing the Possible Rare Reasons for Normal Parathyroid Hormone, Vitamin D and Serum Calcium Levels in a Patient With Severe Osteoporosis and Radiologic Parathyroid Adenoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Alamin","family":"Alkundi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabiu","family":"Momoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4377-2607-7.00035-X","article-title":"Benign neoplasms of the parathyroid gland","author":"Lester DRT","year":"2013","unstructured":"Lester DRT. Benign neoplasms of the parathyroid gland. Head and Neck Pathology. Lester DT, Goldblum JR (ed): Elsevier Inc, 2013. 644-652. 10.1016\/B978-1-4377-2607-7.00035-X"},{"key":"ref2","article-title":"Parathyroid Adenoma","author":"Wolfe SA","year":"2024","unstructured":"Wolfe SA, Sharma S. Parathyroid Adenoma. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref3","article-title":"Normocalcemic Hyperparathyroidism","author":"Leslie SW","year":"2024","unstructured":"Leslie SW, Levine SN. Normocalcemic Hyperparathyroidism. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1024\/0040-5930\/a000172","article-title":"Primary hyperparathyroidism","volume":"68","author":"Suter-Widmer I","year":"2011","unstructured":"Suter-Widmer I, Kraenzlin ME, Meier C. Primary hyperparathyroidism. Ther Umsch. 2011, 68:321-6. 10.1024\/0040-5930\/a000172","journal-title":"Ther Umsch"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-6-24","article-title":"Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level","volume":"6","author":"Gurrado A","year":"2008","unstructured":"Gurrado A, Marzullo A, Lissidini G, Lippolis A, Rubini D, Lastilla G, Testini M. Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level. World J Surg Oncol. 2008, 6:24. 10.1186\/1477-7819-6-24","journal-title":"World J Surg Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0273","article-title":"Primary hyperparathyroidism with a low-normal, atypical serum parathyroid hormone as shown by discordant immunoassay curves","volume":"91","author":"Lafferty FW","year":"2006","unstructured":"Lafferty FW, Hamlin CR, Corrado KR, Arnold A, Shuck JM. Primary hyperparathyroidism with a low-normal, atypical serum parathyroid hormone as shown by discordant immunoassay curves. J Clin Endocrinol Metab. 2006, 91:3826-9. 10.1210\/jc.2006-0273","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0247","article-title":"Primary hyperparathyroidism with low intact PTH levels in a 14-year-old girl","volume":"96","author":"Benaderet AD","year":"2011","unstructured":"Benaderet AD, Burton AM, Clifton-Bligh R, Ashraf AP. Primary hyperparathyroidism with low intact PTH levels in a 14-year-old girl. J Clin Endocrinol Metab. 2011, 96:2325-9. 10.1210\/jc.2011-0247","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03225.x","article-title":"Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas","volume":"69","author":"Bhadada SK","year":"2008","unstructured":"Bhadada SK, Cardenas M, Bhansali A, et al.. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas. Clin Endocrinol (Oxf). 2008, 69:382-5. 10.1111\/j.1365-2265.2008.03225.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref9","unstructured":"Bone mineral density tests. What the numbers mean. (2024). Accessed: October 31, 2024: https:\/\/www.niams.nih.gov\/health-topics\/bone-mineral-density-tests-what-numbers-mean."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.109664","article-title":"Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide","volume":"17","author":"Gupta V","year":"2013","unstructured":"Gupta V. Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide. Indian J Endocrinol Metab. 2013, 17:336-8. 10.4103\/2230-8210.109664","journal-title":"Indian J Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: Further characterization of a new clinical phenotype","volume":"92","author":"Lowe H","year":"2007","unstructured":"Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: Further characterization of a new clinical phenotype. J Clin Endocrinol Metab. 2007, 92:3001-5. 10.1210\/jc.2006-2802","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","article-title":"Romosozumab","author":"Krupa KN","year":"2024","unstructured":"Krupa KN, Parmar M, Delo LF. Romosozumab. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2022.101639","article-title":"Romosozumab improves low bone mineral density in a postmenopausal woman undergoing chronic hemodialysis and treated with a calcium-sensing receptor agonist","volume":"17","author":"Ogata M","year":"2022","unstructured":"Ogata M, Ushimaru S, Fujishima R, Sumi H, Shiizaki K, Tominaga N. Romosozumab improves low bone mineral density in a postmenopausal woman undergoing chronic hemodialysis and treated with a calcium-sensing receptor agonist. Bone Rep. 2022, 17:101639. 10.1016\/j.bonr.2022.101639","journal-title":"Bone Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/314508-reviewing-the-possible-rare-reasons-for-normal-parathyroid-hormone-vitamin-d-and-serum-calcium-levels-in-a-patient-with-severe-osteoporosis-and-radiologic-parathyroid-adenoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T12:01:14Z","timestamp":1731931274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/314508-reviewing-the-possible-rare-reasons-for-normal-parathyroid-hormone-vitamin-d-and-serum-calcium-levels-in-a-patient-with-severe-osteoporosis-and-radiologic-parathyroid-adenoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.73901","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,18]]}}}